ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Valvular Heart Disease Treatment Market Insights, Forecast to 2030
Published Date: December 2024
|
Report Code: QYRE-Auto-3V6289
Home | Market Reports | Health| Health Conditions| Heart & Hypertension
Global Valvular Heart Disease Treatment Market Insights Forecast to 2028
BUY CHAPTERS

Global Valvular Heart Disease Treatment Market Insights, Forecast to 2030

Code: QYRE-Auto-3V6289
Report
December 2024
Pages:115
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Abbott Laboratories
B Braun Melsungen AG
Boston Scientific Corp
Medtronic Inc
CryoLife
Edwards Lifesciences Corporation
LivaNova
Neovasc Inc
Micro Interventional Devices
Symetis SA
Jenavalve Technology
TTK Healthcare Limited
Colibri Heart Valve
Lepu Medical Technology Co.
Braile Biomédica

Valvular Heart Disease Treatment Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Valvular Heart Disease Treatment Market

Valvular Heart Disease Treatment Market

Valvular heart disease is characterized by damage to or a defect in one of the four heart valves namely the mitral valve, aortic valve, tricuspid valve, and pulmonary valve.
Market Analysis and Insights: Global Valvular Heart Disease Treatment Market
The global Valvular Heart Disease Treatment market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers:
This report presents an overview of global market for Valvular Heart Disease Treatment market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Valvular Heart Disease Treatment, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Valvular Heart Disease Treatment, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Valvular Heart Disease Treatment revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Valvular Heart Disease Treatment market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Valvular Heart Disease Treatment revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation

Scope of Valvular Heart Disease Treatment Market Report

Report Metric Details
Report Name Valvular Heart Disease Treatment Market
CAGR 5%
Segment by Type
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Abbott Laboratories, B. Braun Melsungen AG, Boston Scientific Corp., Medtronic, CryoLife Inc., Edwards Lifesciences Corporation, LivaNova PLC, Neovasc Inc., Micro Interventional Devices, Symetis SA, Jenavalve Technology, TTK Healthcare Limited, Colibri Heart Valve, Lepu Medical Technology Co., Braile Biomédica
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Revenue of Valvular Heart Disease Treatment in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Valvular Heart Disease Treatment companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
  • Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
  • Chapter 8: China by Type, and by Application, revenue for each segment.
  • Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
  • Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
  • Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Valvular Heart Disease Treatment revenue, gross margin, and recent development, etc.
  • Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

Who are the main players in the Valvular Heart Disease Treatment Market report?

Ans: The main players in the Valvular Heart Disease Treatment Market are Abbott Laboratories, B. Braun Melsungen AG, Boston Scientific Corp., Medtronic, CryoLife Inc., Edwards Lifesciences Corporation, LivaNova PLC, Neovasc Inc., Micro Interventional Devices, Symetis SA, Jenavalve Technology, TTK Healthcare Limited, Colibri Heart Valve, Lepu Medical Technology Co., Braile Biomédica

What are the Application segmentation covered in the Valvular Heart Disease Treatment Market report?

Ans: The Applications covered in the Valvular Heart Disease Treatment Market report are Hospital & Clinics, Ambulatory Surgical Centers, Research Institutes

What are the Type segmentation covered in the Valvular Heart Disease Treatment Market report?

Ans: The Types covered in the Valvular Heart Disease Treatment Market report are Cardiac Catheterization, Electrocardiogram (ECG), Chest X-Ray, Stress Test, Others

Recommended Reports

Cardiac Valve Devices

Cardiac Drug Markets

Heart Disease Treatments

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Valvular Heart Disease Treatment Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Cardiac Catheterization
1.2.3 Electrocardiogram (ECG)
1.2.4 Chest X-Ray
1.2.5 Stress Test
1.2.6 Others
1.3 Market by Application
1.3.1 Global Valvular Heart Disease Treatment Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Hospital & Clinics
1.3.3 Ambulatory Surgical Centers
1.3.4 Research Institutes
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Valvular Heart Disease Treatment Market Perspective (2019-2030)
2.2 Global Valvular Heart Disease Treatment Growth Trends by Region
2.2.1 Valvular Heart Disease Treatment Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Valvular Heart Disease Treatment Historic Market Size by Region (2019-2024)
2.2.3 Valvular Heart Disease Treatment Forecasted Market Size by Region (2025-2030)
2.3 Valvular Heart Disease Treatment Market Dynamics
2.3.1 Valvular Heart Disease Treatment Industry Trends
2.3.2 Valvular Heart Disease Treatment Market Drivers
2.3.3 Valvular Heart Disease Treatment Market Challenges
2.3.4 Valvular Heart Disease Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Valvular Heart Disease Treatment by Players
3.1.1 Global Valvular Heart Disease Treatment Revenue by Players (2019-2024)
3.1.2 Global Valvular Heart Disease Treatment Revenue Market Share by Players (2019-2024)
3.2 Global Valvular Heart Disease Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Valvular Heart Disease Treatment, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Valvular Heart Disease Treatment Market Concentration Ratio
3.4.1 Global Valvular Heart Disease Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Valvular Heart Disease Treatment Revenue in 2023
3.5 Global Key Players of Valvular Heart Disease Treatment Head office and Area Served
3.6 Global Key Players of Valvular Heart Disease Treatment, Product and Application
3.7 Global Key Players of Valvular Heart Disease Treatment, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Valvular Heart Disease Treatment Breakdown Data by Type
4.1 Global Valvular Heart Disease Treatment Historic Market Size by Type (2019-2024)
4.2 Global Valvular Heart Disease Treatment Forecasted Market Size by Type (2025-2030)
5 Valvular Heart Disease Treatment Breakdown Data by Application
5.1 Global Valvular Heart Disease Treatment Historic Market Size by Application (2019-2024)
5.2 Global Valvular Heart Disease Treatment Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Valvular Heart Disease Treatment Market Size (2019-2030)
6.2 North America Valvular Heart Disease Treatment Market Size by Type
6.2.1 North America Valvular Heart Disease Treatment Market Size by Type (2019-2024)
6.2.2 North America Valvular Heart Disease Treatment Market Size by Type (2025-2030)
6.2.3 North America Valvular Heart Disease Treatment Market Share by Type (2019-2030)
6.3 North America Valvular Heart Disease Treatment Market Size by Application
6.3.1 North America Valvular Heart Disease Treatment Market Size by Application (2019-2024)
6.3.2 North America Valvular Heart Disease Treatment Market Size by Application (2025-2030)
6.3.3 North America Valvular Heart Disease Treatment Market Share by Application (2019-2030)
6.4 North America Valvular Heart Disease Treatment Market Size by Country
6.4.1 North America Valvular Heart Disease Treatment Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Valvular Heart Disease Treatment Market Size by Country (2019-2024)
6.4.3 North America Valvular Heart Disease Treatment Market Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Valvular Heart Disease Treatment Market Size (2019-2030)
7.2 Europe Valvular Heart Disease Treatment Market Size by Type
7.2.1 Europe Valvular Heart Disease Treatment Market Size by Type (2019-2024)
7.2.2 Europe Valvular Heart Disease Treatment Market Size by Type (2025-2030)
7.2.3 Europe Valvular Heart Disease Treatment Market Share by Type (2019-2030)
7.3 Europe Valvular Heart Disease Treatment Market Size by Application
7.3.1 Europe Valvular Heart Disease Treatment Market Size by Application (2019-2024)
7.3.2 Europe Valvular Heart Disease Treatment Market Size by Application (2025-2030)
7.3.3 Europe Valvular Heart Disease Treatment Market Share by Application (2019-2030)
7.4 Europe Valvular Heart Disease Treatment Market Size by Country
7.4.1 Europe Valvular Heart Disease Treatment Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Valvular Heart Disease Treatment Market Size by Country (2019-2024)
7.4.3 Europe Valvular Heart Disease Treatment Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Valvular Heart Disease Treatment Market Size (2019-2030)
8.2 China Valvular Heart Disease Treatment Market Size by Type
8.2.1 China Valvular Heart Disease Treatment Market Size by Type (2019-2024)
8.2.2 China Valvular Heart Disease Treatment Market Size by Type (2025-2030)
8.2.3 China Valvular Heart Disease Treatment Market Share by Type (2019-2030)
8.3 China Valvular Heart Disease Treatment Market Size by Application
8.3.1 China Valvular Heart Disease Treatment Market Size by Application (2019-2024)
8.3.2 China Valvular Heart Disease Treatment Market Size by Application (2025-2030)
8.3.3 China Valvular Heart Disease Treatment Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Valvular Heart Disease Treatment Market Size (2019-2030)
9.2 Asia Valvular Heart Disease Treatment Market Size by Type
9.2.1 Asia Valvular Heart Disease Treatment Market Size by Type (2019-2024)
9.2.2 Asia Valvular Heart Disease Treatment Market Size by Type (2025-2030)
9.2.3 Asia Valvular Heart Disease Treatment Market Share by Type (2019-2030)
9.3 Asia Valvular Heart Disease Treatment Market Size by Application
9.3.1 Asia Valvular Heart Disease Treatment Market Size by Application (2019-2024)
9.3.2 Asia Valvular Heart Disease Treatment Market Size by Application (2025-2030)
9.3.3 Asia Valvular Heart Disease Treatment Market Share by Application (2019-2030)
9.4 Asia Valvular Heart Disease Treatment Market Size by Region
9.4.1 Asia Valvular Heart Disease Treatment Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Valvular Heart Disease Treatment Market Size by Region (2019-2024)
9.4.3 Asia Valvular Heart Disease Treatment Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Valvular Heart Disease Treatment Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Valvular Heart Disease Treatment Market Size by Type
10.2.1 Middle East, Africa, and Latin America Valvular Heart Disease Treatment Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Valvular Heart Disease Treatment Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Valvular Heart Disease Treatment Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Valvular Heart Disease Treatment Market Size by Application
10.3.1 Middle East, Africa, and Latin America Valvular Heart Disease Treatment Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Valvular Heart Disease Treatment Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Valvular Heart Disease Treatment Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Valvular Heart Disease Treatment Market Size by Country
10.4.1 Middle East, Africa, and Latin America Valvular Heart Disease Treatment Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Valvular Heart Disease Treatment Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Valvular Heart Disease Treatment Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Details
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Valvular Heart Disease Treatment Introduction
11.1.4 Abbott Laboratories Revenue in Valvular Heart Disease Treatment Business (2019-2024)
11.1.5 Abbott Laboratories Recent Developments
11.2 B. Braun Melsungen AG
11.2.1 B. Braun Melsungen AG Company Details
11.2.2 B. Braun Melsungen AG Business Overview
11.2.3 B. Braun Melsungen AG Valvular Heart Disease Treatment Introduction
11.2.4 B. Braun Melsungen AG Revenue in Valvular Heart Disease Treatment Business (2019-2024)
11.2.5 B. Braun Melsungen AG Recent Developments
11.3 Boston Scientific Corp.
11.3.1 Boston Scientific Corp. Company Details
11.3.2 Boston Scientific Corp. Business Overview
11.3.3 Boston Scientific Corp. Valvular Heart Disease Treatment Introduction
11.3.4 Boston Scientific Corp. Revenue in Valvular Heart Disease Treatment Business (2019-2024)
11.3.5 Boston Scientific Corp. Recent Developments
11.4 Medtronic
11.4.1 Medtronic Company Details
11.4.2 Medtronic Business Overview
11.4.3 Medtronic Valvular Heart Disease Treatment Introduction
11.4.4 Medtronic Revenue in Valvular Heart Disease Treatment Business (2019-2024)
11.4.5 Medtronic Recent Developments
11.5 CryoLife Inc.
11.5.1 CryoLife Inc. Company Details
11.5.2 CryoLife Inc. Business Overview
11.5.3 CryoLife Inc. Valvular Heart Disease Treatment Introduction
11.5.4 CryoLife Inc. Revenue in Valvular Heart Disease Treatment Business (2019-2024)
11.5.5 CryoLife Inc. Recent Developments
11.6 Edwards Lifesciences Corporation
11.6.1 Edwards Lifesciences Corporation Company Details
11.6.2 Edwards Lifesciences Corporation Business Overview
11.6.3 Edwards Lifesciences Corporation Valvular Heart Disease Treatment Introduction
11.6.4 Edwards Lifesciences Corporation Revenue in Valvular Heart Disease Treatment Business (2019-2024)
11.6.5 Edwards Lifesciences Corporation Recent Developments
11.7 LivaNova PLC
11.7.1 LivaNova PLC Company Details
11.7.2 LivaNova PLC Business Overview
11.7.3 LivaNova PLC Valvular Heart Disease Treatment Introduction
11.7.4 LivaNova PLC Revenue in Valvular Heart Disease Treatment Business (2019-2024)
11.7.5 LivaNova PLC Recent Developments
11.8 Neovasc Inc.
11.8.1 Neovasc Inc. Company Details
11.8.2 Neovasc Inc. Business Overview
11.8.3 Neovasc Inc. Valvular Heart Disease Treatment Introduction
11.8.4 Neovasc Inc. Revenue in Valvular Heart Disease Treatment Business (2019-2024)
11.8.5 Neovasc Inc. Recent Developments
11.9 Micro Interventional Devices
11.9.1 Micro Interventional Devices Company Details
11.9.2 Micro Interventional Devices Business Overview
11.9.3 Micro Interventional Devices Valvular Heart Disease Treatment Introduction
11.9.4 Micro Interventional Devices Revenue in Valvular Heart Disease Treatment Business (2019-2024)
11.9.5 Micro Interventional Devices Recent Developments
11.10 Symetis SA
11.10.1 Symetis SA Company Details
11.10.2 Symetis SA Business Overview
11.10.3 Symetis SA Valvular Heart Disease Treatment Introduction
11.10.4 Symetis SA Revenue in Valvular Heart Disease Treatment Business (2019-2024)
11.10.5 Symetis SA Recent Developments
11.11 Jenavalve Technology
11.11.1 Jenavalve Technology Company Details
11.11.2 Jenavalve Technology Business Overview
11.11.3 Jenavalve Technology Valvular Heart Disease Treatment Introduction
11.11.4 Jenavalve Technology Revenue in Valvular Heart Disease Treatment Business (2019-2024)
11.11.5 Jenavalve Technology Recent Developments
11.12 TTK Healthcare Limited
11.12.1 TTK Healthcare Limited Company Details
11.12.2 TTK Healthcare Limited Business Overview
11.12.3 TTK Healthcare Limited Valvular Heart Disease Treatment Introduction
11.12.4 TTK Healthcare Limited Revenue in Valvular Heart Disease Treatment Business (2019-2024)
11.12.5 TTK Healthcare Limited Recent Developments
11.13 Colibri Heart Valve
11.13.1 Colibri Heart Valve Company Details
11.13.2 Colibri Heart Valve Business Overview
11.13.3 Colibri Heart Valve Valvular Heart Disease Treatment Introduction
11.13.4 Colibri Heart Valve Revenue in Valvular Heart Disease Treatment Business (2019-2024)
11.13.5 Colibri Heart Valve Recent Developments
11.14 Lepu Medical Technology Co.
11.14.1 Lepu Medical Technology Co. Company Details
11.14.2 Lepu Medical Technology Co. Business Overview
11.14.3 Lepu Medical Technology Co. Valvular Heart Disease Treatment Introduction
11.14.4 Lepu Medical Technology Co. Revenue in Valvular Heart Disease Treatment Business (2019-2024)
11.14.5 Lepu Medical Technology Co. Recent Developments
11.15 Braile Biomédica
11.15.1 Braile Biomédica Company Details
11.15.2 Braile Biomédica Business Overview
11.15.3 Braile Biomédica Valvular Heart Disease Treatment Introduction
11.15.4 Braile Biomédica Revenue in Valvular Heart Disease Treatment Business (2019-2024)
11.15.5 Braile Biomédica Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
FEATURED COMPANIES
Abbott Laboratories
B Braun Melsungen AG
Boston Scientific Corp
Medtronic Inc
CryoLife
Edwards Lifesciences Corporation
LivaNova
Neovasc Inc
Micro Interventional Devices
Symetis SA
Jenavalve Technology
TTK Healthcare Limited
Colibri Heart Valve
Lepu Medical Technology Co.
Braile Biomédica
List of Tables
    Table 1. Global Valvular Heart Disease Treatment Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
    Table 2. Key Players of Cardiac Catheterization
    Table 3. Key Players of Electrocardiogram (ECG)
    Table 4. Key Players of Chest X-Ray
    Table 5. Key Players of Stress Test
    Table 6. Key Players of Others
    Table 7. Global Valvular Heart Disease Treatment Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
    Table 8. Global Valvular Heart Disease Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 9. Global Valvular Heart Disease Treatment Market Size by Region (2019-2024) & (US$ Million)
    Table 10. Global Valvular Heart Disease Treatment Market Share by Region (2019-2024)
    Table 11. Global Valvular Heart Disease Treatment Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 12. Global Valvular Heart Disease Treatment Market Share by Region (2025-2030)
    Table 13. Valvular Heart Disease Treatment Market Trends
    Table 14. Valvular Heart Disease Treatment Market Drivers
    Table 15. Valvular Heart Disease Treatment Market Challenges
    Table 16. Valvular Heart Disease Treatment Market Restraints
    Table 17. Global Valvular Heart Disease Treatment Revenue by Players (2019-2024) & (US$ Million)
    Table 18. Global Valvular Heart Disease Treatment Revenue Share by Players (2019-2024)
    Table 19. Global Top Valvular Heart Disease Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Valvular Heart Disease Treatment as of 2023)
    Table 20. Global Valvular Heart Disease Treatment Industry Ranking 2022 VS 2023 VS 2024
    Table 21. Global 5 Largest Players Market Share by Valvular Heart Disease Treatment Revenue (CR5 and HHI) & (2019-2024)
    Table 22. Global Key Players of Valvular Heart Disease Treatment, Headquarters and Area Served
    Table 23. Global Key Players of Valvular Heart Disease Treatment, Product and Application
    Table 24. Global Key Players of Valvular Heart Disease Treatment, Product and Application
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global Valvular Heart Disease Treatment Market Size by Type (2019-2024) & (US$ Million)
    Table 27. Global Valvular Heart Disease Treatment Revenue Market Share by Type (2019-2024)
    Table 28. Global Valvular Heart Disease Treatment Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 29. Global Valvular Heart Disease Treatment Revenue Market Share by Type (2025-2030)
    Table 30. Global Valvular Heart Disease Treatment Market Size by Application (2019-2024) & (US$ Million)
    Table 31. Global Valvular Heart Disease Treatment Revenue Share by Application (2019-2024)
    Table 32. Global Valvular Heart Disease Treatment Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 33. Global Valvular Heart Disease Treatment Revenue Share by Application (2025-2030)
    Table 34. North America Valvular Heart Disease Treatment Market Size by Type (2019-2024) & (US$ Million)
    Table 35. North America Valvular Heart Disease Treatment Market Size by Type (2025-2030) & (US$ Million)
    Table 36. North America Valvular Heart Disease Treatment Market Size by Application (2019-2024) & (US$ Million)
    Table 37. North America Valvular Heart Disease Treatment Market Size by Application (2025-2030) & (US$ Million)
    Table 38. North America Valvular Heart Disease Treatment Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 39. North America Valvular Heart Disease Treatment Market Size by Country (2019-2024) & (US$ Million)
    Table 40. North America Valvular Heart Disease Treatment Market Size by Country (2025-2030) & (US$ Million)
    Table 41. Europe Valvular Heart Disease Treatment Market Size by Type (2019-2024) & (US$ Million)
    Table 42. Europe Valvular Heart Disease Treatment Market Size by Type (2025-2030) & (US$ Million)
    Table 43. Europe Valvular Heart Disease Treatment Market Size by Application (2019-2024) & (US$ Million)
    Table 44. Europe Valvular Heart Disease Treatment Market Size by Application (2025-2030) & (US$ Million)
    Table 45. Europe Valvular Heart Disease Treatment Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 46. Europe Valvular Heart Disease Treatment Market Size by Country (2019-2024) & (US$ Million)
    Table 47. Europe Valvular Heart Disease Treatment Market Size by Country (2025-2030) & (US$ Million)
    Table 48. China Valvular Heart Disease Treatment Market Size by Type (2019-2024) & (US$ Million)
    Table 49. China Valvular Heart Disease Treatment Market Size by Type (2025-2030) & (US$ Million)
    Table 50. China Valvular Heart Disease Treatment Market Size by Application (2019-2024) & (US$ Million)
    Table 51. China Valvular Heart Disease Treatment Market Size by Application (2025-2030) & (US$ Million)
    Table 52. Asia Valvular Heart Disease Treatment Market Size by Type (2019-2024) & (US$ Million)
    Table 53. Asia Valvular Heart Disease Treatment Market Size by Type (2025-2030) & (US$ Million)
    Table 54. Asia Valvular Heart Disease Treatment Market Size by Application (2019-2024) & (US$ Million)
    Table 55. Asia Valvular Heart Disease Treatment Market Size by Application (2025-2030) & (US$ Million)
    Table 56. Asia Valvular Heart Disease Treatment Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 57. Asia Valvular Heart Disease Treatment Market Size by Region (2019-2024) & (US$ Million)
    Table 58. Asia Valvular Heart Disease Treatment Market Size by Region (2025-2030) & (US$ Million)
    Table 59. Middle East, Africa, and Latin America Valvular Heart Disease Treatment Market Size by Type (2019-2024) & (US$ Million)
    Table 60. Middle East, Africa, and Latin America Valvular Heart Disease Treatment Market Size by Type (2025-2030) & (US$ Million)
    Table 61. Middle East, Africa, and Latin America Valvular Heart Disease Treatment Market Size by Application (2019-2024) & (US$ Million)
    Table 62. Middle East, Africa, and Latin America Valvular Heart Disease Treatment Market Size by Application (2025-2030) & (US$ Million)
    Table 63. Middle East, Africa, and Latin America Valvular Heart Disease Treatment Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 64. Middle East, Africa, and Latin America Valvular Heart Disease Treatment Market Size by Country (2019-2024) & (US$ Million)
    Table 65. Middle East, Africa, and Latin America Valvular Heart Disease Treatment Market Size by Country (2025-2030) & (US$ Million)
    Table 66. Abbott Laboratories Company Details
    Table 67. Abbott Laboratories Business Overview
    Table 68. Abbott Laboratories Valvular Heart Disease Treatment Product
    Table 69. Abbott Laboratories Revenue in Valvular Heart Disease Treatment Business (2019-2024) & (US$ Million)
    Table 70. Abbott Laboratories Recent Developments
    Table 71. B. Braun Melsungen AG Company Details
    Table 72. B. Braun Melsungen AG Business Overview
    Table 73. B. Braun Melsungen AG Valvular Heart Disease Treatment Product
    Table 74. B. Braun Melsungen AG Revenue in Valvular Heart Disease Treatment Business (2019-2024) & (US$ Million)
    Table 75. B. Braun Melsungen AG Recent Developments
    Table 76. Boston Scientific Corp. Company Details
    Table 77. Boston Scientific Corp. Business Overview
    Table 78. Boston Scientific Corp. Valvular Heart Disease Treatment Product
    Table 79. Boston Scientific Corp. Revenue in Valvular Heart Disease Treatment Business (2019-2024) & (US$ Million)
    Table 80. Boston Scientific Corp. Recent Developments
    Table 81. Medtronic Company Details
    Table 82. Medtronic Business Overview
    Table 83. Medtronic Valvular Heart Disease Treatment Product
    Table 84. Medtronic Revenue in Valvular Heart Disease Treatment Business (2019-2024) & (US$ Million)
    Table 85. Medtronic Recent Developments
    Table 86. CryoLife Inc. Company Details
    Table 87. CryoLife Inc. Business Overview
    Table 88. CryoLife Inc. Valvular Heart Disease Treatment Product
    Table 89. CryoLife Inc. Revenue in Valvular Heart Disease Treatment Business (2019-2024) & (US$ Million)
    Table 90. CryoLife Inc. Recent Developments
    Table 91. Edwards Lifesciences Corporation Company Details
    Table 92. Edwards Lifesciences Corporation Business Overview
    Table 93. Edwards Lifesciences Corporation Valvular Heart Disease Treatment Product
    Table 94. Edwards Lifesciences Corporation Revenue in Valvular Heart Disease Treatment Business (2019-2024) & (US$ Million)
    Table 95. Edwards Lifesciences Corporation Recent Developments
    Table 96. LivaNova PLC Company Details
    Table 97. LivaNova PLC Business Overview
    Table 98. LivaNova PLC Valvular Heart Disease Treatment Product
    Table 99. LivaNova PLC Revenue in Valvular Heart Disease Treatment Business (2019-2024) & (US$ Million)
    Table 100. LivaNova PLC Recent Developments
    Table 101. Neovasc Inc. Company Details
    Table 102. Neovasc Inc. Business Overview
    Table 103. Neovasc Inc. Valvular Heart Disease Treatment Product
    Table 104. Neovasc Inc. Revenue in Valvular Heart Disease Treatment Business (2019-2024) & (US$ Million)
    Table 105. Neovasc Inc. Recent Developments
    Table 106. Micro Interventional Devices Company Details
    Table 107. Micro Interventional Devices Business Overview
    Table 108. Micro Interventional Devices Valvular Heart Disease Treatment Product
    Table 109. Micro Interventional Devices Revenue in Valvular Heart Disease Treatment Business (2019-2024) & (US$ Million)
    Table 110. Micro Interventional Devices Recent Developments
    Table 111. Symetis SA Company Details
    Table 112. Symetis SA Business Overview
    Table 113. Symetis SA Valvular Heart Disease Treatment Product
    Table 114. Symetis SA Revenue in Valvular Heart Disease Treatment Business (2019-2024) & (US$ Million)
    Table 115. Symetis SA Recent Developments
    Table 116. Jenavalve Technology Company Details
    Table 117. Jenavalve Technology Business Overview
    Table 118. Jenavalve Technology Valvular Heart Disease Treatment Product
    Table 119. Jenavalve Technology Revenue in Valvular Heart Disease Treatment Business (2019-2024) & (US$ Million)
    Table 120. Jenavalve Technology Recent Developments
    Table 121. TTK Healthcare Limited Company Details
    Table 122. TTK Healthcare Limited Business Overview
    Table 123. TTK Healthcare Limited Valvular Heart Disease Treatment Product
    Table 124. TTK Healthcare Limited Revenue in Valvular Heart Disease Treatment Business (2019-2024) & (US$ Million)
    Table 125. TTK Healthcare Limited Recent Developments
    Table 126. Colibri Heart Valve Company Details
    Table 127. Colibri Heart Valve Business Overview
    Table 128. Colibri Heart Valve Valvular Heart Disease Treatment Product
    Table 129. Colibri Heart Valve Revenue in Valvular Heart Disease Treatment Business (2019-2024) & (US$ Million)
    Table 130. Colibri Heart Valve Recent Developments
    Table 131. Lepu Medical Technology Co. Company Details
    Table 132. Lepu Medical Technology Co. Business Overview
    Table 133. Lepu Medical Technology Co. Valvular Heart Disease Treatment Product
    Table 134. Lepu Medical Technology Co. Revenue in Valvular Heart Disease Treatment Business (2019-2024) & (US$ Million)
    Table 135. Lepu Medical Technology Co. Recent Developments
    Table 136. Braile Biomédica Company Details
    Table 137. Braile Biomédica Business Overview
    Table 138. Braile Biomédica Valvular Heart Disease Treatment Product
    Table 139. Braile Biomédica Revenue in Valvular Heart Disease Treatment Business (2019-2024) & (US$ Million)
    Table 140. Braile Biomédica Recent Developments
    Table 141. Research Programs/Design for This Report
    Table 142. Key Data Information from Secondary Sources
    Table 143. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Valvular Heart Disease Treatment Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 2. Global Valvular Heart Disease Treatment Market Share by Type: 2023 VS 2030
    Figure 3. Cardiac Catheterization Features
    Figure 4. Electrocardiogram (ECG) Features
    Figure 5. Chest X-Ray Features
    Figure 6. Stress Test Features
    Figure 7. Others Features
    Figure 8. Global Valvular Heart Disease Treatment Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 9. Global Valvular Heart Disease Treatment Market Share by Application: 2023 VS 2030
    Figure 10. Hospital & Clinics Case Studies
    Figure 11. Ambulatory Surgical Centers Case Studies
    Figure 12. Research Institutes Case Studies
    Figure 13. Valvular Heart Disease Treatment Report Years Considered
    Figure 14. Global Valvular Heart Disease Treatment Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 15. Global Valvular Heart Disease Treatment Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 16. Global Valvular Heart Disease Treatment Market Share by Region: 2023 VS 2030
    Figure 17. Global Valvular Heart Disease Treatment Market Share by Players in 2023
    Figure 18. Global Top Valvular Heart Disease Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Valvular Heart Disease Treatment as of 2023)
    Figure 19. The Top 10 and 5 Players Market Share by Valvular Heart Disease Treatment Revenue in 2023
    Figure 20. North America Valvular Heart Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 21. North America Valvular Heart Disease Treatment Market Share by Type (2019-2030)
    Figure 22. North America Valvular Heart Disease Treatment Market Share by Application (2019-2030)
    Figure 23. North America Valvular Heart Disease Treatment Market Share by Country (2019-2030)
    Figure 24. United States Valvular Heart Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 25. Canada Valvular Heart Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 26. Europe Valvular Heart Disease Treatment Market Size YoY (2019-2030) & (US$ Million)
    Figure 27. Europe Valvular Heart Disease Treatment Market Share by Type (2019-2030)
    Figure 28. Europe Valvular Heart Disease Treatment Market Share by Application (2019-2030)
    Figure 29. Europe Valvular Heart Disease Treatment Market Share by Country (2019-2030)
    Figure 30. Germany Valvular Heart Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. France Valvular Heart Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. U.K. Valvular Heart Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. Italy Valvular Heart Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. Russia Valvular Heart Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 35. Nordic Countries Valvular Heart Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 36. China Valvular Heart Disease Treatment Market Size YoY (2019-2030) & (US$ Million)
    Figure 37. China Valvular Heart Disease Treatment Market Share by Type (2019-2030)
    Figure 38. China Valvular Heart Disease Treatment Market Share by Application (2019-2030)
    Figure 39. Asia Valvular Heart Disease Treatment Market Size YoY (2019-2030) & (US$ Million)
    Figure 40. Asia Valvular Heart Disease Treatment Market Share by Type (2019-2030)
    Figure 41. Asia Valvular Heart Disease Treatment Market Share by Application (2019-2030)
    Figure 42. Asia Valvular Heart Disease Treatment Market Share by Region (2019-2030)
    Figure 43. Japan Valvular Heart Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. South Korea Valvular Heart Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. China Taiwan Valvular Heart Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 46. Southeast Asia Valvular Heart Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 47. India Valvular Heart Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 48. Australia Valvular Heart Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 49. Middle East, Africa, and Latin America Valvular Heart Disease Treatment Market Size YoY (2019-2030) & (US$ Million)
    Figure 50. Middle East, Africa, and Latin America Valvular Heart Disease Treatment Market Share by Type (2019-2030)
    Figure 51. Middle East, Africa, and Latin America Valvular Heart Disease Treatment Market Share by Application (2019-2030)
    Figure 52. Middle East, Africa, and Latin America Valvular Heart Disease Treatment Market Share by Country (2019-2030)
    Figure 53. Brazil Valvular Heart Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 54. Mexico Valvular Heart Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 55. Turkey Valvular Heart Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 56. Saudi Arabia Valvular Heart Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 57. Israel Valvular Heart Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 58. GCC Countries Valvular Heart Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 59. Abbott Laboratories Revenue Growth Rate in Valvular Heart Disease Treatment Business (2019-2024)
    Figure 60. B. Braun Melsungen AG Revenue Growth Rate in Valvular Heart Disease Treatment Business (2019-2024)
    Figure 61. Boston Scientific Corp. Revenue Growth Rate in Valvular Heart Disease Treatment Business (2019-2024)
    Figure 62. Medtronic Revenue Growth Rate in Valvular Heart Disease Treatment Business (2019-2024)
    Figure 63. CryoLife Inc. Revenue Growth Rate in Valvular Heart Disease Treatment Business (2019-2024)
    Figure 64. Edwards Lifesciences Corporation Revenue Growth Rate in Valvular Heart Disease Treatment Business (2019-2024)
    Figure 65. LivaNova PLC Revenue Growth Rate in Valvular Heart Disease Treatment Business (2019-2024)
    Figure 66. Neovasc Inc. Revenue Growth Rate in Valvular Heart Disease Treatment Business (2019-2024)
    Figure 67. Micro Interventional Devices Revenue Growth Rate in Valvular Heart Disease Treatment Business (2019-2024)
    Figure 68. Symetis SA Revenue Growth Rate in Valvular Heart Disease Treatment Business (2019-2024)
    Figure 69. Jenavalve Technology Revenue Growth Rate in Valvular Heart Disease Treatment Business (2019-2024)
    Figure 70. TTK Healthcare Limited Revenue Growth Rate in Valvular Heart Disease Treatment Business (2019-2024)
    Figure 71. Colibri Heart Valve Revenue Growth Rate in Valvular Heart Disease Treatment Business (2019-2024)
    Figure 72. Lepu Medical Technology Co. Revenue Growth Rate in Valvular Heart Disease Treatment Business (2019-2024)
    Figure 73. Braile Biomédica Revenue Growth Rate in Valvular Heart Disease Treatment Business (2019-2024)
    Figure 74. Bottom-up and Top-down Approaches for This Report
    Figure 75. Data Triangulation
    Figure 76. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Samsung SD

SIMILAR REPORTS

Global Valvular Disease Device Market Research Report 2025
Global Transcatheter Heart Valve Replacement and Repair Market Insights Forecast to 2030
Global Heart Valve Repair and Replacement Devices Market Research Report 2024
Global Valvular Disease Interventional Device Market Research Report 2025
Heart Valve Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Transcatheter Mitral Valve Repair Replacement Market Insights Forecast to 2030
Heart Valve Medical Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Surgical Heart Valve Management Products Market Insights Forecast to 2030
Global Heart Valve Repair Products Market Insights Forecast to 2030
Global Heart Valve Replacement and Repair Materials Market Research Report 2025
Global Structural Heart Disease Treatment Devices Market Research Report 2024
Global Heart Valve Repair System Market Research Report 2024
Global Pulmonary Heart Valve Replacement Market Research Report 2024
Congenital Heart Disease Treatment Device Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Heart Valve Management Solutions Market Research Report 2025
Global Structural Heart Devices Market Insights Forecast to 2030
Global Mitral Valve Interventional Devices Market Research Report 2024
Global Aortic Valve Device Market Research Report 2025
Global Minimally Invasive Heart Valve Surgery Devices Market Research Report 2024
Global Diagnostic Interventional Cardiology Devices Market Insights Forecast to 2030

RELATED REPORTS

Global Low-Density Lipoprotein Cholesterol Assay Kit Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-32E19705
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Cardiovascular Informations (CVIS) Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-10A6248
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Pulmonary Arterial Hypertension (PAH) Medicine Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-8I7059
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Heparin Calcium Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-15Y8668
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions